The expression of Wiskott-Aldrich syndrome protein (WASP) is dependent on WASP-interacting protein (WIP)

International Immunology

Volumn 19, Issue 2, 2007, Pages 185-192

  Konno, Akihiro ^a,b   Kirby, Martha ^a   Anderson, Stacie A ^a   Schwartzberg, Pamela L ^a   Candotti, Fabio ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b Yamagata Prefectural Central Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; LENTIVIRUS VECTOR; MESSENGER RNA; PROTEIN WIP; UNCLASSIFIED DRUG; WISKOTT ALDRICH SYNDROME INTERACTING PROTEIN; WISKOTT ALDRICH SYNDROME PROTEIN;

ACTIN POLYMERIZATION; ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE DELETION; GENE MAPPING; GENE MUTATION; GENE TRANSFER; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION REGULATION; WISKOTT ALDRICH SYNDROME;

BLOTTING, WESTERN; CARRIER PROTEINS; CELL LINE; FLOW CYTOMETRY; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSFECTION; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 33846604634     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxl135     Document Type: Article

References (56)

1. Ochs, H. D. 1998. The Wiskott-Aldrich syndrome. Springer Semin. Immunopathol. 19:435.
2. Schurman, S. H. and Candotti, F. 2003. Autoimmunity in Wiskott-Aldrich syndrome. Curr. Opin. Rheumatol. 15:446.
3. Derry, J. M., Ochs, H. D. and Francke, U. 1994. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78:635.
4. Badour, K., Zhang, J. and Siminovitch, K. A. 2003. The Wiskott-Aldrich syndrome protein: Forging the link between actin and cell activation. Immunol. Rev. 192:98.
5. Notarangelo, L. D. and Ochs, H. D. 2003. Wiskott-Aldrich syndrome: A model for defective actin reorganization, cell trafficking and synapse formation. Curr. Opin. Immunol. 15:585.
6. Burns, S., Cory, G. O., Vainchenker, W. and Thrasher, A. J. 2004. Mechanisms of WASp-mediated hematologic and immunologic disease. Blood 104:3454.
7. Miki, H., Miura, K. and Takenawa, T. 1996. N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases. EMBO J. 15:5326.
8. Kim, A. S., Kakalis, L. T., Abdul-Manan, N., Liu, G. A. and Rosen, M. K. 2000. Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature 404:151.
9. Ramesh, N., Anton, I. M., Hartwig, J. H. and Geha, R. S. 1997. WIP, a protein associated with Wiskott-Aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells. Proc. Natl Acad. Sci. USA 94:14671.
10. Stewart, D. M., Tian, L. and Nelson, D. L. 1999. Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein. J. Immunol. 162:5019.
11. Machesky, L. M. and Insall, R. H. 1998. Scar1 and the related Wiskott-Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex. Curr. Biol. 8:1347.
12. Yarar, D., To, W., Abo, A. and Welch, M. D. 1999. The Wiskott-Aldrich syndrome protein directs actin-based motility by stimulating actin nucleation with the Arp2/3 complex. Curr. Biol. 9:555.
13. Kinley, A. W., Weed, S. A., Weaver, A. M. et al. 2003. Cortactin interacts with WIP in regulating Arp2/3 activation and membrane protrusion. Curr. Biol. 13:384.
14. Snapper, S. B., Rosen, F. S., Mizoguchi, E. et al. 1998. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity 9:81.
15. Zhang, J., Shehabeldin, A., da Cruz, L. A. et al. 1999. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J. Exp. Med. 190:1329.
16. Anton, I. M., de la Fuente, M. A., Sims, T. N. et al. 2002. WIP deficiency reveals a differential role for WIP and the actin cytoskeleton in T and B cell activation. Immunity 16:193.
17. Luthi, J. N., Gandhi, M. J. and Drachman, J. G. 2003. X-linked thrombocytopenia caused by a mutation in the Wiskott-Aldrich syndrome (WAS) gene that disrupts interaction with the WAS protein (WASP)-interacting protein (WIP). Exp. Hematol. 31:150.
18. Jin, Y., Mazza, C., Christie, J. R. et al. 2004. Mutations of the Wiskott-Aldrich syndrome protein (WASP): Hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood 104:4010.
19. Sasahara, Y., Rachid, R., Byrne, M. J. et al. 2002. Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. Mol. Cell 10:1269.
20. Martinez-Quiles, N., Rohatgi, R., Anton, I. M. et al. 2001. WIP regulates N-WASP-mediated actin polymerization and filopodium formation. Nat. Cell Biol. 3:484.
21. Candotti, F., Facchetti, F., Blanzuoli, L., Stewart, D. M., Nelson, D. L. and Blaese, R. M. 1999. Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott-Aldrich syndrome patients carrying 'null' mutations. Gene Ther. 6:1170.
22. Stewart, D. M., Treiber-Held, S., Kurman, C. C., Facchetti, F., Notarangelo, L. D. and Nelson, D. L. 1996. Studies of the expression of the Wiskott-Aldrich syndrome protein. J. Clin. Invest. 97:2627.
23. Rubinson, D. A., Dillon, C. P., Kwiatkowski, A. V. et al. 2003. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33:401.
24. Dombroski, D., Houghtling, R. A., Labno, C. M. et al. 2005. Kinase-independent functions for Itk in TCR-induced regulation of Vav and the actin cytoskeleton. J. Immunol. 174:1385.
25. Haas, D. L., Case, S. S., Crooks, G. M. and Kohn, D. B. 2000. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors. Mol. Ther. 2:71.
26. Parolini, O., Berardelli, S., Riedl, E. et al. 1997. Expression of Wiskott-Aldrich syndrome protein (WASP) gene during hematopoietic differentiation. Blood 90:70.
27. Wada, T., Jagadeesh, G. J., Nelson, D. L. and Candotti, F. 2002. Retrovirus-mediated WASP gene transfer corrects Wiskott-Aldrich syndrome T cell dysfunction. Hum. Gene Ther. 13:1039.
28. Volkman, B. F., Prehoda, K. E., Scott, J. A., Peterson, F. C. and Lim, W. A. 2002. Structure of the N-WASP EVH1 domain-WIP complex: Insight into the molecular basis of Wiskott-Aldrich syndrome. Cell 111:565.
29. Silvin, C., Belisle, B. and Abo, A. 2001. A role for Wiskott-Aldrich syndrome protein in T-cell receptor-mediated transcriptional activation independent of actin polymerization. J. Biol. Chem. 276:21450.
30. Wada, T., Schurman, S. H., Otsu, M. et al. 2001. Somatic mosaicism in Wiskott-Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. Proc. Natl Acad. Sci. USA 98:8697.
31. Wada, T., Konno, A., Schurman, S. H. et al. 2003. Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings. J. Clin. Invest. 111:1389.
32. Konno, A., Wada, T., Schurman, S. H. et al. 2004. Differential contribution of Wiskott-Aldrich syndrome protein to selective advantage in T- and B-cell lineages. Blood 103:676.
33. Wada, T., Schurman, S. H., Jagadeesh, G. J., Garabedian, E. K., Nelson, D. L. and Candotti, F. 2004. Multiple patients with revertant mosaicism in a single Wiskott-Aldrich syndrome family. Blood 104:1270.
34. Anton, I. M., Saville, S. P., Byrne, M. J. et al. 2003. WIP participates in actin reorganization and ruffle formation induced by PDGF. J. Cell Sci. 116:2443.
35. Anton, I. M., Lu, W., Mayer, B. J., Ramesh, N. and Geha, R. S. 1998. The Wiskott-Aldrich syndrome protein-interacting protein (WIP) binds to the adaptor protein Nck. J. Biol. Chem. 273:20992.
36. Savoy, D. N., Billadeau, D. D. and Leibson, P. J. 2000. Cutting edge: WIP, a binding partner for Wiskott-Aldrich syndrome protein, cooperates with Vav in the regulation of T cell activation. J. Immunol. 164:2866.
37. Rajmohan, R., Meng, L., Yu, S. and Thanabalu, T. 2006. WASP suppresses the growth defect of Saccharomyces cerevisiae las17Delta strain in the presence of WIP. Biochem. Biophys. Res. Commun. 342:529.
38. Sawa, M. and Takenawa, T. 2006. Caenorhabditis elegans WASP-interacting protein homologue WIP-1 is involved in morphogenesis through maintenance of WSP-1 protein levels. Biochem. Biophys. Res. Commun. 340:709.
39. Thrasher, A. J. 2002. WASp in immune-system organization and function. Nat. Rev. Immunol. 2:635.
40. Imai, K., Morio, T., Zhu, Y. et al. 2004. Clinical course of patients with WASP gene mutations. Blood 103:456.
41. MacCarthy-Morrogh, L., Gaspar, H. B., Wang, Y. C. et al. 1998. Absence of expression of the Wiskott-Aldrich syndrome protein in peripheral blood cells of Wiskott-Aldrich syndrome patients. Clin. Immunol. Immunopathol. 88:22.
42. Huang, M. M., Tsuboi, S., Wong, A. et al. 2000. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins. Gene Ther. 7:314.
43. Dupre, L., Aiuti, A., Trifari, S. et al. 2002. Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity 17:157.
44. Jones, G. E., Zicha, D., Dunn, G. A., Blundell, M. and Thrasher, A. 2002. Restoration of podosomes and chemotaxis in Wiskott-Aldrich syndrome macrophages following induced expression of WASp. Int. J. Biochem. Cell Biol. 34:806.
45. Dupre, L., Trifari, S., Follenzi, A. et al. 2004. Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction. Mol. Ther. 10:903.
46. Klein, C., Nguyen, D., Liu, C. H. et al. 2003. Gene therapy for Wiskott-Aldrich syndrome: Rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice. Blood 101:2159.
47. Strom, T. S., Gabbard, W., Kelly, P. F., Cunningham, J. M. and Nienhuis, A. W. 2003. Functional correction of T cells derived from patients with the Wiskott-Aldrich syndrome (WAS) by transduction with an oncoretroviral vector encoding the WAS protein. Gene Ther. 10:803.
48. Strom, T. S., Turner, S. J., Andreansky, S. et al. 2003. Defects in T-cell-mediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells. Blood 102:3108.
49. Charrier, S., Stockholm, D., Seye, K. et al. 2005. A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Gene Ther. 12:597.
50. Martin, F., Toscano, M. G., Blundell, M. et al. 2005. Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences. Gene Ther. 12:715.
51. Dupre, L., Marangoni, F., Scaramuzza, S. et al. 2006. Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/ cDNA-containing lentiviral vector and nonlethal irradiation. Hum. Gene Ther. 17:303.
52. Dewey, R. A., Avedillo Diez, I., Ballmaier, M. et al. 2006. Retroviral WASP gene transfer into human hematopoietic stem cells reconstitutes the actin cytoskeleton in myeloid progeny cells differentiated in vitro. Exp. Hematol. 34:1161.
53. Charrier, S., Dupre, L., Scaramuzza, S. et al. 2006. Lentiviral vectors targeting WASP expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients. Gene Ther. Epub ahead of print, Oct 19.
54. Symons, M., Derry, J. M., Karlak, B. et al. 1996. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 84:723.
55. Kettner, A., Kumar, L., Anton, I. M. et al. 2004. WIP regulates signaling via the high affinity receptor for immunoglobulin E in mast cells. J. Exp. Med. 199:357.
56. Shcherbina, A., Miki, H., Kenney, D. M., Rosen, F. S., Takenawa, T. and Remold-O'Donnell, E. 2001. WASP and N-WASP in human platelets differ in sensitivity to protease calpain. Blood 98:2988.